Primary prevention of cardiovascular disease: an umbrella review of non-pharmacological interventions
DOI:
https://doi.org/10.23938/ASSN.0316Keywords:
Cardiovascular, Non-Prescription Intervention, Umbrella Review, Systematic Reviews and Meta-AnalysesAbstract
Background. The aim of this study is to determine the effectiveness of non-pharmacological interventions for prevention of cardiovascular disease (CVD) events and mortality in healthy adults or those at high risk of CVD.
Methods. An umbrella review about primary prevention of non-pharmacological interventions was undertaken in key databases as PubMed Health, Effective Health Care Program AHRQ, McMaster University and the Cochrane Plus until July 2017. The primary outcomes were the relative risk of fatal and non-fatal CVD events, and mortality. Secondary outcomes were adverse events.
Results. Twenty-four reviews were included of which thirteen reported outcomes of interest. Four of these found a pooled statistically significant risk reduction: dietary supplements of vitamin D, increased consumption of omega 3 fatty acids, Qigong, and counselling or education to modify more than one cardiovascular risk factor. Seven studies reported adverse events but minor or insignificant with respect to the control group.
Conclusions. Four non-pharmacological interventions have been shown to provide a statistically significant reduction in risk of CVD events or overall mortality, with minor adverse events if any. Further research should aim for higher methodological quality and longer follow-up of interventions to establish if these interventions, alone or in combination, translate into definite long-term health benefits.
Keywords. Cardiovascular. Non-prescription intervention. Umbrella review. Systematic reviews and meta-analyses.
Downloads
References
ROBINSON JG. Starting primary prevention earlier with statins. Am J Cardiol 2014; 114:1437-1442.
NICE guidelines could put 12 million UK adults on statins. BMJ 2017; 358: j3674.
GOLDACRE B. Mass treatment with statins. BMJ 2014; 349: g4745.
TOWNSEND N, NICHOLS M, SCARBOROUGH P, RAYNER M. Cardiovascular disease in Europe 2015: epidemiological update. Eur Heart J 2015; 36: 2673-2674.
WHO, United States Centers for Disease Control and Prevention (US CDC) Global Hearts Initiative. Working together to beat cardiovascular disease. [Access on: 20/03/2017] Available from http://www.who.int/cardiovascular_diseases/global-hearts/en/
THE JOANNA BRIGGS INSTITUTE. Joanna Briggs Institute Reviewers’ Manual: 2014 edition. Supplement. Adelaide: The Joanna Briggs Institute 2014. [Accessed 01/09/2017]. Available from: http://joannabriggs.org/assets/docs/sumari/ReviewersManual-Methodology-JBI_Umbrella%20Reviews-2014.pdf
SMITH V, DEVANE D, BEGLEY CM, CLARKE M. Methodology in conducting a systematic review of systematic reviews of healthcare interventions. BMC Med Res Methodol 2011; 11: 15. DOI: 10.1186/1471-2288-11-15.
SHEA BJ, GRIMSHAW JM, WELLS GA, BOERS M, ANDERSSON N, HAMEL C ET AL. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 2007; 7: 10. DOI: 10.1186/1471-2288-7-10.
HIGGINS JP, THOMPSON SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002; 21: 1539-1558.
KETOLA E, SIPILÄ R, MÄKELÄ M. Effectiveness of individual lifestyle interventions in reducing cardiovascular disease and risk factors. Ann Med 2000; 32: 239-251.
EBRAHIM S, TAYLOR F, WARD K, BESWICK A, BURKE M, DAVEY SMITH G. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev 2011; 1. CD001561. DOI: 10.1002/14651858.CD001561.pub3.
AL-KHUDAIRY L, FLOWERS N, WHEELHOUSE R, GHANNAM O, HARTLEY L, STRANGES S ET AL. Vitamin C supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2017; 3. CD011114. DOI: 10.1002/14651858.CD011114.pub2.
BJELAKOVIC G, NIKOLOVA D, GLUUD LL, SIMONETTI RG, GLUUD C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2012: 3: CD007176. doi: 10.1002/14651858.CD007176.pub2.
BJELAKOVIC G, GLUUD LL, NIKOLOVA D, WHITFIELD K, WETTERSLEV J, SIMONETTI RG ET AL. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2014; 1. CD007470. DOI: 10.1002/14651858.CD007470.pub2.
REES K, HARTLEY L, DAY C, FLOWERS N, CLARKE A, STRANGES S. Selenium supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013; 1. CD009671. DOI: 10.1002/14651858.CD009671.pub2.
FLOWERS N, HARTLEY L, TODKILL D, STRANGES S, REES K. Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2014; 12. CD010405. DOI: 10.1002/14651858.CD010405.pub2.
HARTLEY L, CLAR C, GHANNAM O, FLOWERS N, STRANGES S, REES K. Vitamin K for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2015; 9. CD011148. DOI: 10.1002/14651858.CD011148.pub2.
FORTMANN SP, BURDA BU, SENGER CA, LIN JS, WHITLOCK EP. Vitamin, Mineral, and Multivitamin Supplements for the Primary Prevention of Cardiovascular Disease and Cancer: A Systematic Evidence Review for the U.S. Ann Intern Med 2013; 159: 824-834.
HOOPER L, BARTLETT C, DAVEY SMITH G, EBRAHIM S. Advice to reduce dietary salt for prevention of cardiovascular disease. Cochrane Database Syst Rev 2004; 1. CD003656. DOI: 10.1002/14651858.CD003656.pub2.
HARTLEY L, IGBINEDION E, HOLMES J, FLOWERS N, THOROGOOD M, CLARKE A. Increased consumption of fruit and vegetables for the primary prevention of cardiovascular diseases. Cochrane Database Syst Rev 2013; 6. CD009874. DOI: 10.1002/14651858.CD009874.pub2.
REES K, HARTLEY L, FLOWERS N, CLARKE A, HOOPER L, THOROGOOD M ET AL. 'Mediterranean' dietary pattern for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013; 8. CD009825.
MARTIN N, GERMANÒ R, HARTLEY L, ADLER AJ, REES K. Nut consumption for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2015; 9. CD011583. DOI: 10.1002/14651858.CD011583.pub2.
HARTLEY L, FLOWERS N, HOLMES J, CLARKE A, STRANGES S, HOOPER L ET AL. Green and black tea for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013; 6.CD009934. DOI: 10.1002/14651858.CD009934.pub2.
HARTLEY L, MAY MD, LOVEMAN E, COLQUITT JL, REES K. Dietary fibre for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2016; 1.CD011472. DOI: 10.1002/14651858.CD011472.pub2.
HOOPER L, THOMPSON RL, HARRISON RA, SUMMERBELL CD, MOORE H, WORTHINGTON HV ET AL. Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst Rev 2004; 4.CD003177. DOI: 10.1002/14651858.CD003177.pub2.
AL-KHUDAIRYL, HARTLEY L, CLAR C, FLOWERS N, HOOPER L, REES K. Omega 6 fatty acids for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2015; 11.CD011094. DOI: 10.1002/14651858.CD011094.pub2.
UTHMAN OA, HARTLEY L, REES K, TAYLOR F, EBRAHIM S, CLARKE A. Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries. Cochrane Database Syst Rev 2015; 8. DOI: 10.1002/14651858.CD011163.pub2.
SERON P, LANAS F, PARDO-HERNANDEZ H, BONFILL COSP X. Exercise for people with high cardiovascular risk. Cochrane Database Syst Rev 2014; 8.CD009387. DOI: 10.1002/14651858.CD009387.pub2.
HARTLEY L, LEE MS, KWONG JSW, FLOWERS N, TODKILL D, ERNST E ET AL. Qigong for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2015; 6.CD010390. DOI: 10.1002/14651858.CD010390.pub2.
HARTLEY L, FLOWERS N, LEE MS, ERNST E, REES K. Tai chi for primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2014; 4.CD010366. DOI: 10.1002/14651858.CD010366.pub2.
HARTLEY L, DYAKOVA M, HOLMES J, CLARKE A, LEE MS, ERNST E ET AL. Yoga for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2014; 5.CD010072. DOI: 10.1002/14651858.CD010072.pub2.
HARTLEY L, MAVRODARIS A, FLOWERS N, ERNST E, REES K. Transcendental meditation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2014; 12.CD010359. DOI: 10.1002/14651858.CD010359.pub2.
WIDMER RJ, COLLINS NM, COLLINS CS, WEST CP, LERMAN LO, LERMAN A. Digital health interventions for the prevention of cardiovascular disease: a systematic review and meta-analysis. Mayo Clin Proc 2015; 90: 469-480. DOI: 10.1016/j.mayocp.2014.12.026.
KROGSBØLL LT, JØRGENSEN KJ, GRØNHØJ LARSEN C, GØTZSCHE PC. General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database Syst Rev 2012; 10.CD009009. DOI: 10.1002/14651858.CD009009.pub2.
NQA.ORG. What is Qigong?. National Qigong Association. [online] Available from: http://www.nqa.org/ [Accessed 22/09/2017].
THEODORATOU E, TZOULAKI I, ZGAGA L, IOANNIDIS JPA. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ. 2014; 1: g2035. DOI: https://doi.org/10.1136/bmj.g2035.
SEUNG-KWON M, WOONG J, BELONG C, SEUNG-WON O, SANG MIN P, BON-KWON K ET AL. Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. BMJ 2013; 346: f10. DOI: https://doi.org/10.1136/bmj.f10.
BROWN WV, BAYS HE, LA FORGE R, SIKAND G. JCL Roundtable. Gender differences in risk reduction with lifestyle changes. J Clin Lipidol 2015; 9: 486-495.
SOMMER I, GRIEBLER U, MAHLKNECHT P, THALER K, BOUSKILL K, GARTLEHNER G ET AL. Socioeconomic inequalities in non-communicable diseases and their risk factors: an overview of systematic reviews. BMC Public Health 2015; 15: 914. DOI: 10.1186/s12889-015-2227-y.
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Anales del Sistema Sanitario de Navarra
![Creative Commons License](http://i.creativecommons.org/l/by-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.